Published October 20, 2010
Acute Pain: Overview of Management
NUCYNTA®, a molecule with mu-opioid agonist activity and norepinephrine
reuptake inhibition, has been approved for the relief of moderate to
severe acute pain in patients 18 years of age or older. NUCYNTA® has
been clinically tested in multiple pain models and found to combine
opioid efficacy with favorable gastrointestinal tolerability.
Click here for pdf.